Dudediligence.

Tonix Pharmaceuticals Holding Corp

TNXPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.8MSep ’24$2.6MDec ’24$2.4MMar ’25$2.0MJun ’25$3.3MSep ’25$5.4MDec ’25$6.9MMar ’26$13.5MJun ’26
Net income, by quarter
−$14.2MSep ’24−$22.1MDec ’24−$16.8MMar ’25−$28.3MJun ’25−$32.0MSep ’25−$46.9MDec ’25−$40.2MMar ’26−$40.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on file$7.8M$10.1M$13.1M
Gross profitnone on filenone on file$3.0M$2.3M$6.5M
Operating income−$92.3M−$112.1M−$118.4M−$136.7M−$125.7M
Net income−$92.3M−$110.2M−$116.7M−$130.0M−$124.0M
Operating cash flow−$75.6M−$98.1M−$102.0M−$60.9M−$99.8M
Free cash flow−$110.9M−$146.2M−$109.9M−$61.0M−$103.2M
Cash$178.7M$120.2M$24.9M$98.8M$207.6M
Debtnone on filenone on file$8.9M$7.5Mnone on file
Shares outstanding15.6M12.4M20.9K4.4M12.8M